This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow [Supplementary Material]
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pring, M. E.
Right arrow Articles by Sim, F. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pring, M. E.
Right arrow Articles by Sim, F. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?
The Journal of Bone and Joint Surgery (American) 83:1630-1642 (2001)
© 2001 The Journal of Bone and Joint Surgery, Inc.

Scientific Article

Chondrosarcoma of the Pelvis

A Review of Sixty-four Cases

Maya E. Pring, MD, Kristy L. Weber, MD, K. Krishnan Unni, MD and Franklin H. Sim, MD

Investigation performed at the Mayo Clinic and Mayo Foundation, Rochester, Minnesota
Maya E. Pring, MD
K. Krishnan Unni, MD
Franklin H. Sim, MD
Department of Orthopedic Surgery, Mayo Clinic and Mayo Foundation, 200 First Street S.W., Rochester, MN 55905

Kristy L. Weber, MD
Section of Orthopaedic Oncology, Department of Surgical Oncology, The University of Texas, M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 444, Houston, TX 77030

The authors did not receive grants or outside funding in support of their research or preparation of this manuscript. They did not receive payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, educational institution, or other charitable or nonprofit organization with which the authors are affiliated or associated.

Background: Treatment of pelvic chondrosarcoma is a difficult problem for the musculoskeletal oncologist. Poor rates of survival and high rates of local recurrence after surgical treatment have been reported in previous studies. The present study was designed to review the long-term oncologic and functional outcomes of surgical management in a large series of patients with pelvic chondrosarcoma who were treated at a single institution.

Methods: The cases of sixty-four patients with localized pelvic chondrosarcoma that had been surgically treated between 1975 and 1996 were reviewed retrospectively. The study was limited to patients who had received no previous treatment for chondrosarcoma. There were forty-one male and twenty-three female patients who had a mean age of forty-seven years (range, fifteen to eighty-eight years). The patients were followed for a minimum of three years or until death. The median duration of follow-up of the living patients was 140 months (range, thirty-nine to 295 months).

Results: Thirty-three of the sixty-four patients were first seen with grade-1 chondrosarcoma; twenty-three, with grade-2; one, with grade-3; and seven, with grade-4 (dedifferentiated chondrosarcoma). Thirteen patients had a hemipelvectomy to achieve local tumor control, whereas fifty-one patients underwent a limb-salvage procedure. Twelve patients (19%) had local recurrence, and eleven (17%) had distant metastases. At the time of the final follow-up, forty-four patients (69%) were alive without evidence of disease, thirteen (20%) had died of the disease, six (9%) had died of unrelated causes, and one (2%) was alive with disease. Less than a wide surgical margin correlated with local recurrence (p = 0.014). High-grade tumors correlated with poor overall survival (p < 0.001). All patients who had a limb-salvage procedure were able to walk at the time of the final follow-up, and they had a mean functional score of 77%, according to the system of the Musculoskeletal Tumor Society.

Conclusions: Aggressive surgical resection of pelvic chondrosarcoma results in long-term survival of the majority of patients. There is a high correlation between tumor grade and overall or disease-free survival.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 ptjournalHome page
L. A Beck, M. J Einertson, M. H Winemiller, R. W DePompolo, K. M Hoppe, and F. F Sim
Functional Outcomes and Quality of Life After Tumor-Related Hemipelvectomy
Physical Therapy, August 1, 2008; 88(8): 916 - 927.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
R. K. Heck Jr., T. D. Peabody, and M. A. Simon
Staging of Primary Malignancies of Bone
CA Cancer J Clin, November 1, 2006; 56(6): 366 - 375.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
H. Morioka, H. Yabe, S. Kaneko, H. Takaishi, T. Ueda, M. Watanabe, K. Kobayashi, and Y. Toyama
Large chondrosarcoma of the rib invading the mediastinum and the spine
J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 986 - 987.
[Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
L. Newkirk, Y. Vater, D. Oxorn, M. Mulligan, and E. Conrad
Intraoperative TEE for the management of pulmonary tumour embolism during chondroblastic osteosarcoma resection: [L'ETO peroperatoire comme mesure diagnostique d'une embolie tumorale pulmonaire pendant la resection d'un osteosarcome chondroblastique]
Can J Anesth, November 1, 2003; 50(9): 886 - 890.
[Abstract] [Full Text] [PDF]